Beam Therapeutics Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.02M0.02M51.84M60.92M377.71M63.52M
Gross Profit 0.02M0.02M51.84M60.92M377.71M63.52M
Operating items
Research & Development 54.62M103.18M387.09M311.59M437.38M367.56M
Selling, General & Administrative 20.55M29.61M57.22M87.81M116.81M111.53M
Other Operating Expenses -3.17M-61.83M
Operating Expenses 75.17M132.78M444.31M399.40M554.19M479.09M
Operating Income -75.15M-132.76M-392.46M-338.48M-176.49M-415.57M
EBIT -75.15M-132.76M-392.46M-338.48M-176.49M-415.57M
Non-operating items
Interest & Investment Income 2.23M1.05M-0.01M15.30M46.68M49.09M
Other Non Operating Income -5.40M-63.40M-1.00M23.90M7.50M2.27M
Non Operating Income -3.17M-61.83M21.83M78.30M45.32M38.87M
Net income details
EBT -72.93M-194.59M-370.64M-260.18M-131.16M-376.70M
Tax Provisions 3.41M1.40M0.10M
Profit After Tax -78.33M-194.59M-370.64M-289.09M-132.53M-376.74M
Equity Income 0.52M17.69M-25.50M-18.59M-14.09M
Income from Continuing Operations -72.93M-194.59M-370.64M-263.59M-132.56M-376.80M
Consolidated Net Income -72.93M-194.59M-370.64M-263.59M-132.56M-376.80M
Income towards Parent Company -72.93M-194.59M-370.64M-263.59M-132.56M-376.80M
Preferred Dividend Payments 12.71M1.28M
Net Income towards Common Stockholders -91.04M-195.87M-370.64M-289.09M-132.53M-376.74M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 51.34M57.97M68.14M70.47M81.50M82.81M
Shares Outstanding (Diluted Average) 6.48M46.73M64.23M70.02M77.15M82.31M
EBITDA -78.31M-194.62M-370.68M-291.47M-129.49M-376.67M
Shares Outstanding 7.33M57.25M68.39M71.28M81.63M83.63M